Stage IIIC Cutaneous Melanoma AJCC v7
Oncology
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Stage IIIC Cutaneous Melanoma AJCC v7?
There are 1 clinical trial targeting Stage IIIC Cutaneous Melanoma AJCC v7 tracked by BioSniper.
What is the prevalence of Stage IIIC Cutaneous Melanoma AJCC v7?
The estimated prevalence of Stage IIIC Cutaneous Melanoma AJCC v7 is approximately 75.0 per 100,000 population.
Deep-dive into Stage IIIC Cutaneous Melanoma AJCC v7
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis